L 130
Alternative Names: Conjugated Psilocin™; L-130; Psilocin MucateLatest Information Update: 25 Nov 2024
Price :
$50 *
At a glance
- Originator Lobe Sciences
- Class Analgesics; Behavioural disorder therapies; Indole alkaloids; Mood stabilisers; Small molecules; Tryptamines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Cluster headache
Most Recent Events
- 19 Nov 2024 Lobe Sciences and Alera Pharma receives a second patent allowance for Conjugated Psilocin™
- 02 Oct 2024 Lobe Science files for patent protection for the compositions of matter, methods of use and methods of production for conjugated psilocin worldwide
- 02 Oct 2024 Lobe Sciences has patent protection for Psilocin Mucate (Conjugated psilocin)in USA